<p>PS-1 (M146L) AD and control human skin fibroblasts treated with 25 nM BK (A) or 250 nM BK (B) for 0–30 min were immunoblotted for active JNK with phospho-epitope specific antibodies and analyzed by ECL. Fold activation was quantified as a percentage of basal activation in buffer treated cells (0 min) normalized to tubulin and is graphically represented for active JNK (A–B). Representative immunoblots shown display differential JNK activation profiles between PS-1 (M146L) AD and control fibroblasts (C). All graphs show mean±S.E. Statistical analysis was performed via t-test with *p-value<0.05 and ***p<0.0005; n = 4.</p
<p>(A and B) Adherent fibroblasts were stimulated with the indicated concentrations of PDGF-BB for t...
<p>Western blot analysis of pJNK and JNK in non-differentiated (St-T1, first line; KdS1, second line...
<p>Human adipocytes were incubated with 1 nM BPA for 24h and exposed to 20 µM SP600125 for 1 h. a) C...
<p>PS-1 (M146L) AD and control human skin fibroblasts treated with 25 nM BK (A) or 250 nM BK (B) for...
<p>PS-1 (M146L) AD and control human skin fibroblasts were treated with 25 nM BK or 250 nM BK for 0–...
<p>PS-1 (M146L) AD and normal control human skin fibroblasts were treated with 250 µM H<sub>2</sub>O...
<p>Control human skin fibroblasts and those from AD and Trisomy 21 patients were treated with 250 nM...
<p>Control human skin fibroblasts and those from AD and Trisomy 21 patients were treated with 250 nM...
<p>PS-1 (M146L) AD and normal control human skin fibroblasts were treated with Gamma secretase inhib...
<p>PS-1 (M146L) AD and control fibroblasts were pre-treated with DMSO vehicle control or SP 600125 i...
<p>(A) Representative confocal fluorescent micrographs of differentiated N1E-115 cells immunostained...
The effect of the selective non-peptide antagonist for NK1 receptors (+/-)CP 96,345 on cellular tran...
<p>Trisomy 21 and PS-1 (M146L) AD fibroblasts plus normal control human skin fibroblasts were treate...
<p>(A) mESCs transfected with siJNK were incubated in the presence or absence of 50 ng/ml FGF4 and t...
<p>PS-1, PS-2 and control non-AD fibroblasts (CTRL) were treated with 25 nM PMA for the indicated ti...
<p>(A and B) Adherent fibroblasts were stimulated with the indicated concentrations of PDGF-BB for t...
<p>Western blot analysis of pJNK and JNK in non-differentiated (St-T1, first line; KdS1, second line...
<p>Human adipocytes were incubated with 1 nM BPA for 24h and exposed to 20 µM SP600125 for 1 h. a) C...
<p>PS-1 (M146L) AD and control human skin fibroblasts treated with 25 nM BK (A) or 250 nM BK (B) for...
<p>PS-1 (M146L) AD and control human skin fibroblasts were treated with 25 nM BK or 250 nM BK for 0–...
<p>PS-1 (M146L) AD and normal control human skin fibroblasts were treated with 250 µM H<sub>2</sub>O...
<p>Control human skin fibroblasts and those from AD and Trisomy 21 patients were treated with 250 nM...
<p>Control human skin fibroblasts and those from AD and Trisomy 21 patients were treated with 250 nM...
<p>PS-1 (M146L) AD and normal control human skin fibroblasts were treated with Gamma secretase inhib...
<p>PS-1 (M146L) AD and control fibroblasts were pre-treated with DMSO vehicle control or SP 600125 i...
<p>(A) Representative confocal fluorescent micrographs of differentiated N1E-115 cells immunostained...
The effect of the selective non-peptide antagonist for NK1 receptors (+/-)CP 96,345 on cellular tran...
<p>Trisomy 21 and PS-1 (M146L) AD fibroblasts plus normal control human skin fibroblasts were treate...
<p>(A) mESCs transfected with siJNK were incubated in the presence or absence of 50 ng/ml FGF4 and t...
<p>PS-1, PS-2 and control non-AD fibroblasts (CTRL) were treated with 25 nM PMA for the indicated ti...
<p>(A and B) Adherent fibroblasts were stimulated with the indicated concentrations of PDGF-BB for t...
<p>Western blot analysis of pJNK and JNK in non-differentiated (St-T1, first line; KdS1, second line...
<p>Human adipocytes were incubated with 1 nM BPA for 24h and exposed to 20 µM SP600125 for 1 h. a) C...